Literature DB >> 2858053

Catecholamine modulation of rapid potassium shifts during exercise.

M E Williams, E V Gervino, R M Rosa, L Landsberg, J B Young, P Silva, F H Epstein.   

Abstract

Plasma potassium rises during muscular exercise and falls rapidly when exercise is stopped. Since the sympathoadrenal system is stimulated with exertion and both alpha- and beta-adrenergic agonists affect internal potassium homeostasis, we studied the influence of catecholamines on potassium shifts during and after exercise. Six healthy subjects were given maximal exercise stress tests under three conditions: with no medication (control), during beta-blockade with propranolol, and during alpha-blockade with phentolamine. Compared with a peak rise in plasma potassium of 1.23 +/- 0.27 mmol per liter (mean +/- S.E.M.) during the control study, propranolol caused a rise of 1.89 +/- 0.35 (P less than 0.01) and a sustained elevation during recovery. Phentolamine diminished the rise of potassium (0.70 +/- 0.21 mmol per liter; P less than 0.01) and lowered the potassium level throughout recovery. These effects of catecholamines were independent of the venous pH, the plasma bicarbonate and serum glucose levels, and urinary potassium excretion, and they did not appear to be due to insulin. High norepinephrine and epinephrine levels confirmed the release of catecholamines capable of stimulating alpha- and beta-receptors. Exercise work did not differ among the groups. beta-Adrenergic receptors appear to moderate the acute hyperkalemia of exercise, whereas alpha-adrenergic receptors act to enhance hyperkalemia and may protect against hypokalemia when exertion ceases.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2858053     DOI: 10.1056/NEJM198503283121304

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  39 in total

1.  Selectivity of antagonist and partial agonist activity of celiprolol in normal subjects.

Authors:  N M Wheeldon; D G McDevitt; B J Lipworth
Journal:  Br J Clin Pharmacol       Date:  1992-10       Impact factor: 4.335

2.  Evaluation of the beta 2 adrenoceptor agonist/antagonist activity of formoterol and salmeterol.

Authors:  A Grove; B J Lipworth
Journal:  Thorax       Date:  1996-01       Impact factor: 9.139

3.  Hormonal regulation of potassium shifts during graded exhausting exercise.

Authors:  F J Laso; J M González-Buitrago; C Martín Ruiz; S de Castro
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1991

4.  Beta-blockers, trimethoprim-sulfamethoxazole, and the risk of hyperkalemia requiring hospitalization in the elderly: a nested case-control study.

Authors:  Matthew A Weir; David N Juurlink; Tara Gomes; Muhammad Mamdani; Daniel G Hackam; Arsh K Jain; Amit X Garg
Journal:  Clin J Am Soc Nephrol       Date:  2010-07-01       Impact factor: 8.237

5.  A comparison of the effects of flosequinan, a new vasodilator, and propranolol on sub-maximal exercise in healthy volunteers.

Authors:  H M Lewis; M J Kendall; S R Smith; J R Bratty
Journal:  Br J Clin Pharmacol       Date:  1989-05       Impact factor: 4.335

6.  Familial thyrotoxic periodic paralysis.

Authors:  W M Kufs; M McBiles; T Jurney
Journal:  West J Med       Date:  1989-04

7.  Hypokalaemia in severe head trauma.

Authors:  S Pomeranz; S Constantini; Z H Rappaport
Journal:  Acta Neurochir (Wien)       Date:  1989       Impact factor: 2.216

8.  Expression of the beta 2 adrenoceptor partial agonist/antagonist activity of salbutamol in states of low and high adrenergic tone.

Authors:  A Grove; L C McFarlane; B J Lipworth
Journal:  Thorax       Date:  1995-02       Impact factor: 9.139

9.  Evaluation of a Portable Automated Serum Chemistry Analyzer for Field Assessment of Harlequin Ducks, Histrionicus histrionicus.

Authors:  Michael K Stoskopf; Daniel M Mulcahy; Daniel Esler
Journal:  Vet Med Int       Date:  2010-02-22

10.  A 31P-n.m.r. study of the acute effects of beta-blockade on the bioenergetics of skeletal muscle during contraction.

Authors:  R A Challiss; D J Hayes; G K Radda
Journal:  Biochem J       Date:  1987-08-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.